The Journal of Organic Chemistry
ARTICLE
4.40 (dd, J = 14.4, 10.2 Hz, 1H), 3.91 (dd, J = 14.4, 6.0 Hz, 1H), 2.33 (s,
3H); 13C NMR (75 MHz, CDCl3) δ 11.3, 34.7, 46.9, 122.3, 124.9, 125.0,
125.4, 125.9, 127.1, 127.8, 128.7, 128.8, 129.1, 129.4, 129.5, 129.8, 131.1,
131.3, 131.8, 132.3, 135.7, 155.1, 171.5; IR (KBr) v 3066, 2935, 1601,
1511, 1377, 1363, 1127, 831, 736 cmÀ1. HRMS (ESI) calcd for
C26H20N2NaO3S [M+Na]+: 463.1087. Found: 463.1090. HPLC anal-
ysis: Chiralpak OD-H, i-propanol/hexane = 30:70, flow rate 1.0 mL/
min, λ = 254 nm, tmajor = 6.2 min, tminor = 6.7 min.
1377, 1248, 831, 748 cmÀ1. HRMS (ESI) calcd for C19H17BrN2NaO4S
[M+Na]+: 470.9985. Found: 470.9982. HPLC analysis: Chiralpak AD-H,
i-propanol/hexane = 20:80, flow rate 1.0 mL/min, λ = 254 nm, tmajor
8.0 min, tminor = 9.4 min.
=
(S)-5-(2-(2-Bromophenyl)-2-(4-chlorophenylthio)ethyl)-3-
methyl-4-nitroisoxazole (4s). Yellow solid; 43.0 mg, 95% yield;
81% ee; [α]D25 = À29.5 (c 1.13, CHCl3); mp 108.4À109.3 °C; 1H NMR
(300 MHz, CDCl3) δ 7.53À7.46 (m, 2H), 7.31À7.12 (m, 6H), 5.37 (t,
J = 7.8 Hz, 1H), 3.84 (dd, J = 14.7, 7.8 Hz, 1H), 3.71 (dd, J = 14.7, 7.8 Hz,
1H), 2.46 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 11.4, 33.8, 48.8, 124.0,
128.0, 128.5, 129.1, 129.6, 131.1, 133.1, 134.1, 134.3, 137.7, 155.4, 170.7;
IR (KBr) v 3063, 2900, 1601, 1518, 1475, 1416, 1381, 1094, 831,
772 cmÀ1. HRMS (ESI) calcd for C18H14BrClN2NaO3S [M+Na]+:
474.9489. Found: 474.9493. HPLC analysis: Chiralpak AD-H, i-propa-
nol/hexane = 20:80, flow rate 1.0 mL/min, λ = 254 nm, tmajor = 6.5 min,
tminor = 7.1 min.
(S)-3-Methyl-4-nitro-5-(2-(phenylthio)-2-(thiophen-2-yl)-
ethyl)isoxazole (4n). Yellow solid; 24.3 mg, 70% yield; 72% ee;
25
1
[α]D = À60.7 (c 0.47, CHCl3); mp 72.9À74.5 °C; H NMR (300
MHz, CDCl3) δ 7.37À7.20 (m, 6H), 6.87 (d, J = 3.3 Hz, 2H), 5.10 (t, J =
7.8 Hz, 1H), 3.83 (d, J = 7.8 Hz, 2H), 2.47 (s, 3H); 13C NMR (75 MHz,
CDCl3) δ 11.4, 35.5, 45.4, 125.3, 125.7, 126.7, 128.2, 132.7, 133.2, 142.7,
155.4, 171.1; IR (KBr) v 3115, 2931, 1611, 1521, 1413, 1377, 831, 748,
724 cmÀ1. HRMS (ESI) calcd for C16H14N2NaO3S2 [M+Na]+:
369.0338. Found: 369.0342. HPLC analysis: Chiralpak AD-H, etha-
nol/hexane = 30:70, flow rate 1.0 mL/min, λ = 254 nm, tminor = 8.0 min,
tmajor = 10.5 min.
(S)-5-(2-(2-Bromophenyl)-2-(naphthalen-2-ylthio)ethyl)-
3-methyl-4-nitroisoxazole (4t). Yellow solid; 45.5 mg, 97% yield;
25
88% ee; [α]D = À67.5 (c 1.15, CHCl3); mp 108.9À110.1 °C; 1H
(S)-5-(2-Cyclopropyl-2-(phenylthio)ethyl)-3-methyl-4-ni-
NMR (300 MHz, CDCl3) δ 7.84 (s, 1H), 7.80À7.72 (m, 3H),
7.56À7.47 (m, 5H), 7.34À7.29 (m, 1H), 7.15À7.13 (m, 1H), 5.57 (t,
J = 7.8 Hz, 1H), 3.89 (dd, J = 14.7, 7.8 Hz, 1H), 3.75 (dd, J = 14.7, 7.8
Hz, 1H), 2.23 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 11.2, 34.2,
48.4, 124.0, 126.5, 126.6, 127.5, 128.0, 128.5, 128.7, 129.3, 129.5,
130.1, 131.5, 132.4, 133.1, 133.3, 138.1, 155.3, 170.9; IR (KBr) v
25
troisoxazole (4o). Yellow solid; 29.0 mg, 95% yield; 80% ee; [α]D
=
À27.8 (c 0.73, CHCl3); mp 53.2À54.7 °C; 1H NMR (300 MHz,
CDCl3) δ 7.44À7.41 (m, 2H), 7.30À7.25 (m, 3H), 3.52 (d, J = 7.5
Hz, 2H), 2.89 (m, 1H), 2.47 (s, 3H), 1.01À0.66 (m, 1H), 0.65À0.50 (m,
2H), 0.39À0.0.34 (m, 1H), 0.18À0.15 (m, 1H); 13C NMR (75 MHz,
CDCl3) δ 5.4, 6.2, 11.5, 16.1, 34.6, 52.0, 127.8, 128.9, 132.7, 133.5,
155.3, 172.5; IR (KBr) v 3082, 3003, 1602, 1516, 1377, 1362, 1128, 831,
751 cmÀ1. HRMS (ESI) calcd for C15H16N2NaO3S [M+Na]+:
327.0774. Found: 327.0775. HPLC analysis: Chiralpak AD-H, etha-
nol/hexane = 30:70, flow rate 1.0 mL/min, λ = 254 nm, tminor = 7.0 min,
tmajor = 8.8 min.
3047, 2928, 1604, 1511, 1379, 1361, 1133, 831, 804, 780, 760 cmÀ1
.
HRMS (ESI) calcd for C22H17BrN2NaO3S [M+Na]+: 491.0035.
Found: 491.0040. HPLC analysis: Chiralpak AD-H, i-propanol/
hexane = 20:80, flow rate 1.0 mL/min, λ = 254 nm, tmajor
9.2 min, tminor = 10.0 min.
=
(S)-5-(2-(Benzylthio)-2-(2-bromophenyl)ethyl)-3-methyl-
4-nitroisoxazole (4u). Yellow solid; 18.6 mg, 43% yield; 45% ee; mp
61.2À61.9 °C; [α]D25 = À30.4 (c 0.75, CHCl3); 1H NMR (300 MHz,
CDCl3) δ 7.65À7.60 (m, 1H), 7.51À7.48 (m, 1H), 7.36À7.28 (m, 1H),
7.27À7.18 (m, 5H), 7.16À7.13 (m, 1H), 4.87 (t, J = 7.8 Hz, 1H), 3.73
(dd, J = 14.7, 7.8 Hz, 1H), 3.61 (dd, J = 14.7, 8.4 Hz, 1H), 3.65 (s, 2H),
2.51 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 11.6, 33.8, 36.2, 45.3, 123.9,
127.1, 128.1, 128.5, 128.8, 129.1, 129.3, 132.9, 136.9, 139.0, 155.3, 170.9;
IR (KBr) v 3052, 2938, 1607, 1517, 1416, 1380, 1024, 826, 752,
723 cmÀ1. HRMS (ESI) calcd for C19H17BrN2NaO3S [M+Na]+:
455.0035. Found: 455.0044. HPLC analysis: Chiralpak AD-H, i-propa-
nol/hexane = 20:80, flow rate 1.0 mL/min, λ = 254 nm, tmajor = 6.3 min,
tminor = 7.1 min.
(S)-5-(2-(2-Bromophenyl)-2-(p-tolylthio)ethyl)-3-methyl-
4-nitroisoxazole (4p). Yellow solid; 41.6 mg, 96% yield; 90% ee;
25
1
[α]D = À28.7 (c 1.13, CHCl3); mp 93.8À95.0 °C; H NMR (300
MHz, CDCl3) δ 7.53À7.45 (m, 2H), 7.32À7.05 (m, 6H), 5.35 (t, J = 7.8
Hz, 1H), 3.82 (dd, J = 14.7, 7.8 Hz, 1H), 3.72 (dd, J = 14.7, 7.8 Hz, 1H),
2.44 (s, 3H), 2.31 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 11.5, 21.1,
33.9, 48.9, 124.0, 127.8, 128.5, 128.9, 129.3, 129.7, 133.0, 133.3, 138.1,
138.3, 155.3, 171.1; IR (KBr) v 3063, 2924, 1601, 1511, 1381, 1129,
1025, 831, 774 cmÀ1. HRMS (ESI) calcd for C19H17BrN2NaO3S [M
+Na]+: 455.0035. Found: 455.0035. HPLC analysis: Chiralpak AD-H, i-
propanol/hexane = 20:80, flow rate 1.0 mL/min, λ = 254 nm, tmajor
5.9 min, tminor = 6.6 min.
=
(S)-5-(2-(2-Bromophenyl)-2-(o-tolylthio)ethyl)-3-methyl-
4-nitroisoxazole (4q). Yellow solid; 35.9 mg, 83% yield; 91% ee;
(À)-5-(2-(2-Bromophenyl)-2-(4-methoxyphenylthio)ethyl)-
3-methylisoxazol-4-amine (5). To a solution of 4e (0.419 g,
25
1
[α]D = À24.4 (c 0.95, CHCl3); mp 72.0À72.8 °C; H NMR (300
MHz, CDCl3) δ 7.60À7.32 (m, 4H), 7.18À7.09 (m, 4H), 5.39 (t, J = 7.8
Hz, 1H), 3.84 (dd, J = 14.7, 7.8 Hz, 1H), 3.73 (dd, J = 14.7, 7.8 Hz, 1H),
2.44 (s, 3H), 2.40 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 11.5, 20.6,
34.2, 47.8, 124.0, 126.5, 128.0, 128.2, 128.7, 129.4, 130.5, 131.9, 133.0,
133.5, 138.2, 140.7, 155.3, 171.0; IR (KBr) v 3056, 2903, 1599,
1513, 1470, 1418, 1384, 831, 753 cmÀ1. HRMS (ESI) calcd for
C19H17BrN2NaO3S [M+Na]+: 455.0035. Found: 455.0021. HPLC
analysis: Chiralpak AD-H, i-propanol/hexane = 20:80, flow rate
1.0 mL/min, λ = 254 nm, tmajor = 5.2 min, tminor = 5.6 min.
(S)-5-(2-(2-Bromophenyl)-2-(4-methoxyphenylthio)ethyl)-
3-methyl-4-nitroisoxazole (4r). Yellow solid; 41.6 mg, 93% yield;
91% ee; [α]D25 = À19.6 (c 1.33, CHCl3); mp 101.8À102.6 °C; 1H NMR
(300 MHz, CDCl3) δ 7.52À7.50 (m, 1H), 7.40À7.37 (m, 1H)
7.31À7.26 (m, 3H) 7.12À7.10 (m, 1H), 6.78 (d, J = 8.7 Hz, 2H), 5.25
(t, J = 7.8 Hz, 1H), 3.82 (dd, J = 15.0, 7.8 Hz, 1H), 3.78 (s, 3H), 3.71 (dd,
J = 15.0, 7.8 Hz, 1H), 2.45 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 11.5,
33.7, 49.3, 55.2, 114.5, 122.7, 124.2, 127.8, 128.5, 129.3, 133.1, 136.0,
138.2, 155.4, 160.1, 171.3; IR (KBr) v 3010, 2838, 1606, 1521, 1494,
1.0 mmol) in 20 mL of THF was added SnCl2 2H2O (0.677 g, 3.0 mmol)
3
and dropwised conc. HCl (1.0 mL). The reaction mixture was stirred at
room temperature for 2 h, poured into a cold solution of 10% NaOH
(20 mL), and extracted with ethyl acetate (3 Â 20 mL). The combined
organic layer was washed with water and then dried over Na2SO4 and
finally concentrated. The residue mixture was purified by flash column
chromatography on silica gel (petroleum ether/ethyl acetate = 3:1) to give
25
compound 5 as a colorless oil in 335.5 mg. 80% yield; 91% ee; [α]D
=
À19.6 (c 1.33, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.49À7.47 (m,
1H), 7.42À7.40 (m, 1H), 7.28À7.23 (m, 3H), 7.09À7.04 (m, 1H),
6.77À6.74 (m, 2H), 4.50 (t, J = 7.5 Hz, 1H), 3.76 (s, 3H), 3.30À3.16 (m,
2H), 2.39 (br, 2H), 2.17 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 9.2, 31.5,
50.8, 55.2, 114.4, 122.1, 123.5, 124.5, 127.5, 128.7, 128.8, 132.9, 135.6,
139.8, 153.7, 154.9, 159.8; IR (KBr) v 2926, 2852, 1646, 1494, 1468,
1401, 1387, 1250, 1028, 831, 750 cmÀ1. HRMS (ESI) calcd for
C19H19BrN2NaO2S [M+Na]+: 441.0243. Found: 441.0264. HPLC anal-
ysis: Chiralpak AD-H, ethanol/hexane = 30:70, flow rate 1.0 mL/min, λ =
254 nm, tmajor = 7.8 min, tminor = 15.2 min.
7857
dx.doi.org/10.1021/jo2012779 |J. Org. Chem. 2011, 76, 7849–7859